Actual Medicinal Product (AMP) Kentera 3.9mg/24hours patches (DE Pharmaceuticals)

Stability Information

Stability
not_set logo We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.
Notes
There are no stability notes available for this medicine.
Generic
Oxybutynin
Formulation
Oxybutynin 3.9mg/24hours transdermal patches
  • Oxybutynin
    • Oxybutynin 3.9mg/24hours transdermal patches

      • Kentera 3.9mg/24hours patches (DE Pharmaceuticals)